Education
About Us
Working with TipRanks
Follow Us
Encompass Health (EHC)
NYSE:EHC
EHC Stock Chart & Stats
$105.39
$0.72(0.79%)
At close: 4:00 PM EST
$105.39
$0.72(0.79%)
Day’s Range― - ―
52-Week Range$92.53 - $127.99
Previous CloseN/A
Volume95.02K
Average Volume (3M)1.22M
Market Cap
$10.60B
Enterprise Value$10.87B
Total Cash (Recent Filing)$48.70M
Total Debt (Recent Filing)$2.66B
Price to Earnings (P/E)19.0
Beta0.58
Next Earnings
Apr 29, 2026EPS Estimate
1.5Next Dividend Ex-DateN/A
Dividend Yield0.65%
Share Statistics
EPS (TTM)1.46
Shares Outstanding100,615,974
10 Day Avg. Volume1,661,823
30 Day Avg. Volume1,221,689
Financial Highlights & Ratios
PEG Ratio0.78
Price to Book (P/B)3.32
Price to Sales (P/S)1.80
P/FCF Ratio-14.46
Enterprise Value/Market Cap1.03
Enterprise Value/Revenue1.88
Enterprise Value/Gross Profit4.29
Enterprise Value/Ebitda8.10
Forecast
1Y Price Target
$146.75Price Target Upside39.24% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering5
EPS Forecast (FY)5.82
Revenue Forecast (FY)$6.45B
Bulls Say, Bears Say
Bulls Say
Capacity ExpansionAccelerated development and a plan to add smaller-format hospitals, backed by low leverage and healthy cash flows, should enable capacity growth and capture unmet patient demand.
Demand DynamicsAging demographics and demand that is relatively insensitive to economic cycles support steady patient volumes and underpin predictable revenue streams.
Earnings And GuidanceReported EBITDA exceeded expectations and management issued guidance modestly above consensus, reinforcing confidence in near-term earnings momentum.
Bears Say
Cash Flow And Capital SpendingHigher maintenance and development spending is likely to restrain free cash flow growth, limiting cash available for reinvestment or debt reduction.
Operational Volume PressureConsolidation of treatment units is creating a modest volume headwind that could constrain patient throughput in affected markets.
Reimbursement RiskA major Medicare Advantage payor has increased claim denials and reduced referral-to-admission conversion, requiring appeals and regulatory engagement to protect admissions.
Encompass Health News
EHC FAQ
What was Encompass Health’s price range in the past 12 months?
Encompass Health lowest stock price was $92.53 and its highest was $127.99 in the past 12 months.
What is Encompass Health’s market cap?
Encompass Health’s market cap is $10.60B.
When is Encompass Health’s upcoming earnings report date?
Encompass Health’s upcoming earnings report date is Apr 29, 2026 which is in 77 days.
How were Encompass Health’s earnings last quarter?
Encompass Health released its earnings results on Feb 05, 2026. The company reported $1.46 earnings per share for the quarter, beating the consensus estimate of $1.302 by $0.158.
Is Encompass Health overvalued?
According to Wall Street analysts Encompass Health’s price is currently Undervalued.
Does Encompass Health pay dividends?
Encompass Health pays a Quarterly dividend of $0.19 which represents an annual dividend yield of 0.65%. See more information on Encompass Health dividends here
What is Encompass Health’s EPS estimate?
Encompass Health’s EPS estimate is 1.5.
How many shares outstanding does Encompass Health have?
Encompass Health has 100,615,974 shares outstanding.
What happened to Encompass Health’s price movement after its last earnings report?
Encompass Health reported an EPS of $1.46 in its last earnings report, beating expectations of $1.302. Following the earnings report the stock price went up 5.856%.
Which hedge fund is a major shareholder of Encompass Health?
Currently, no hedge funds are holding shares in EHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Encompass Health Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$146.75 (39.24% Upside)
$146.75 (39.24% Upside)
Blogger Sentiment
Bullish
EHC Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 244.5K Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Negative
Last 7 Days ▲ 0.7%
Last 30 Days ▼ 3.6%
Last 30 Days ▼ 3.6%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
7.56%
12-Months-Change
Fundamentals
Return on Equity
25.13%
Trailing 12-Months
Asset Growth
8.49%
Trailing 12-Months
Company Description
Encompass Health
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates in two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families. As of June 1, 2022, it operated 149 hospitals, 252 home health locations, and 99 hospice locations in 42 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
EHC Company Deck
EHC Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial performance—robust revenue and EBITDA growth, record free cash flow, improved labor metrics, quality outcomes above industry averages and active capital deployment—offset by targeted payer and regulatory challenges (notably a meaningful MA conversion decline with a specific national plan, RCD adjudication efforts in select markets, and some unit consolidations). Management presented clear mitigation actions (appeals strategy, Palmetir analytics, small-format hospital strategy) and provided constructive 2026 guidance, so positives materially outweigh negatives.View all EHC earnings summariesEHC Stock 12 Month Forecast
Average Price Target
$146.75
▲(39.24% Upside)
Technical Analysis
DaVita
―
Fresenius Medical Care
―
Tenet Healthcare
―
The Ensign Group
―
Universal Health
―
Ownership Overview
1.24% Insiders
30.63% Mutual Funds
1.33% Other Institutional Investors
44.45% Public Companies and
Individual Investors